F. Nagahama

Standardization of [F-18]FDG PET/CT for response evaluation by the Radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multicenter phase II trial

Kazunori Kubota, U. Tateishi, J. Tsuchiya, 2018, Japanese Journal of Radiology.

Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea

M. Ogura, K. Tobinai, T. Uchida, 2020, Japanese journal of clinical oncology.

Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)

G. Cavaletti, K. Muro, B. Glimelius, 2022, JNCI cancer spectrum.

Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma

T. Yamauchi, K. Izutsu, Y. Kwong, 2023, Journal of clinical and experimental hematopathology : JCEH.

Asian Multinational Phase II Study of Darinaparsin in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

K. Izutsu, Y. Kwong, H. Kang, 2021, Blood.

Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study

K. Izutsu, Y. Kwong, H. Kang, 2023, Blood advances.